                </a></li></ul></div><p><strong>Figure 2. </strong></p><a id="article1.body1.sec2.fig2.caption1.p1" name="article1.body1.sec2.fig2.caption1.p1"></a><p>
                  <em>cno<sup>2</sup>
                  </em> zygotic null mutants display gain and loss of progenitors.</p>
<a id="article1.body1.sec2.fig2.caption1.p2" name="article1.body1.sec2.fig2.caption1.p2"></a><p>All panels show lateral views of stage 11 embryos stained with an α-Eve antibody.</p>
<a id="article1.body1.sec2.fig2.caption1.p3" name="article1.body1.sec2.fig2.caption1.p3"></a><p>(A) Eve wildtype (wt) expression in a subset of dorsal muscle/heart progenitors and founder cells (2–3 cells) per hemisegment.</p>
<a id="article1.body1.sec2.fig2.caption1.p4" name="article1.body1.sec2.fig2.caption1.p4"></a><p>(B) <em>cno<sup>2</sup>
                  </em> mutants show gain (arrow), loss (arrowhead) or a wildtype number (asterisk) of Eve<sup>+</sup> progenitors in different hemisegments.</p>
<a id="article1.body1.sec2.fig2.caption1.p5" name="article1.body1.sec2.fig2.caption1.p5"></a><p>(C) Embryos in which N<sup>Act</sup>, Wg and Ras<sup>Act</sup> are simultaneously expressed in the mesoderm display a <em>cno<sup>2</sup>
